Evidence map›Paper›PMID 29253018›Full record

ArticlePloS one2017

New roles for nuclear EGFR in regulating the stability and translation of mRNAs associated with VEGF signaling.

Klaus Dittmann, Claus Mayer, Stefan Czemmel, Stephan M Huber, H Peter Rodemann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. RNA-binding protein p54Cell death & disease · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Klaus DittmannDivision of Radiobiology and Molecular Environmental Research, University of Tuebingen, Tuebingen, Germany.ORCID http://orcid.org/0000-0003-3433-7480
Claus MayerDivision of Radiobiology and Molecular Environmental Research, University of Tuebingen, Tuebingen, Germany.
Stefan CzemmelQuantitative Biology Center (QBiC), University of Tuebingen, Tuebingen, Germany.
Stephan M HuberDepartment of Radiation Oncology, University of Tuebingen, Tuebingen, Germany.
H Peter RodemannDivision of Radiobiology and Molecular Environmental Research, University of Tuebingen, Tuebingen, Germany.
German Cancer Research Center · DEQuantitative Biology Center

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell membrane-associated epidermal growth factor receptor (EGFR) translocates into a perinuclear/nuclear location upon stimulation, where it complexes with mRNAs. Treatment with radiation and cisplatin decreases the amounts of mRNAs present within this complex. Gene array analyses of mRNAs in complex with immunoprecipitated nEGFR revealed significant enrichment of different mRNA species compared to the control immunoprecipitation. Functional annotation with help of DAVID Gene Ontology Analysis identified under other terms the HIF-1A/VEGF signaling pathway as one of the top scoring KEGG pathways. RT-PCR and western blots revealed the radiation-induced expression of mRNAs and proteins involved in HIF-1A/VEGF signaling. Simultaneously, the levels of the corresponding validated miRNAs within the complex containing nEGFR and mRNAs were decreased. This finding argues that an mRNA/miRNA/nEGFR complex regulates protein expression. Indeed, we detected the GW182, AGO2, PABPC1 and cNOT1 proteins, which belong to the deadenylase complex, in a complex with nuclear EGFR. Erlotinib-mediated inhibition of EGFR kinase reduced the radiation-induced increase in mRNA expression. In this context, erlotinib reduced AGO2 phosphorylation by the EGFR kinase at residue Y393, which was associated with increased cNOT1 deadenylase activity and reduced mRNA stability. To prove the roles of miRNAs in this context, we transfected cells with an inhibitor of Hsa-mir-1180p5, which targets the NFATC4 mRNA, an mRNA associated with VEGF signaling, or pretreated cells with erlotinib. Indeed, Hsa-mir-1180p5 knockdown increased and the erlotinib treatment decreased the expression of the NFATC4 protein. The expression of the NFATC4 protein controlled the cloning efficiency and radiosensitivity of A549 and FaDu tumor cells. Thus, this study is the first to show that a membrane-located tyrosine kinase receptor, such as EGFR, is internalized to a nuclear/perinuclear location upon exposure to stress and modulates the stability and translation of miRNA-selected mRNAs. This mechanism enables cells to directly express proteins in response to EGFR activation and may contribute to treatment resistance in EGFR-overexpressing tumors.

Indexed as

Protein BiosynthesisRNA StabilitySignal TransductionA549 CellsAdenosine TriphosphateCell NucleusCell SurvivalClone CellsDNA, ComplementaryErbB ReceptorsHumansNFATC Transcription FactorsProtein BindingRNA-Induced Silencing ComplexRNA, MessengerTranscription FactorsAdenosine TriphosphateCNOT1 protein, humanDNA, ComplementaryErbB ReceptorsNFATC Transcription FactorsRNA-Induced Silencing ComplexRNA, MessengerTranscription FactorsVascular Endothelial Growth Factor A

Identifiers

PMID29253018
PMCPMC5734708
OpenAlexW2776547780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.